hepatic toxicity
transient elevations of liver function tests
patients
symptomatic hepatitis
resembling
resembling viral hepatitis
beginning within the first
weeks of therapy
syndrome
fever
icterus
weakness
nausea
abdominal pain
weeks after drug withdrawal
rare cases of chronic hepatitis
late onset hepatitis
serious hepatotoxicity
occurring
patients
fatal cases of submassive hepatic necrosis
postnecrotic cirrhosis
chronic hepatitis
granulomatous hepatitis
rare manifestation of methyldopa
active ingredient
aldomet
hepatotoxicity
patients
liver cirrhosis
acute hepatitis
alternative therapy
risk of additional hepatotoxicity
methyldopa
patient
liver disease
methyldopa therapy
frequent monitoring of liver function tests
months of therapy
methyldopa-associated hepatitis in pregnant patients
false-positive maternal serum alpha-fetoprotein
msafp
mechanism of methyldopa hepatotoxicity
delayed hypersensitivity
accumulation of metabolites
late-onset cases
year-old woman with hypertension
diabetes
acute renal failure
clinical picture of sepsis
taking methyldopa
autopsy
disseminated nonnecrotizing granulomas
liver
spleen
lung
lymph nodes
bone marrow
findings of myocarditis
evidence of infection
including tuberculosis
year-old man with hypertension
severe cholestatic liver disease
years
beginning methyldopa mg per day
evidence of viral
obstructive disease
hematologic side effects
hemolytic anemia
methyldopa-provoked autoantibody
associated positive direct coombs test
patients on chronic therapy
cases of neutropenia
pure red blood cell aplasia
thrombocytopenia
positive le cells
rheumatoid factor
case of methyldopa-associated neutropenia
methyldopa-dependent antibody against granulocytes
year-old man with hypertension
pure red blood cell aplasia
months
starting methyldopa therapy
coombs test
immunoglobulin levels
bone marrow biopsy
absence of erythroid precursors
evidence of hemolysis
infection
erythroblastosis
days after drug withdrawal
year-old woman with diabetes
hypertension
thrombocytopenia
elevated ana titer
methyldopa
thrombocytopenia
thrombotic stroke
platelet count
ana titer
substitution with nifedipine
cases of methyldopa-associated thrombocytopenia
antiplatelet igg antibody
year-old man with hypertension
coronary artery disease
asystole during carotid massage during methyldopa
active ingredient
aldomet
therapy
discontinuation of the drug
asystole
rechallenge
year-old man with chronic obstructive pulmonary disease
hypertension
new signs
symptoms of congestive heart failure
new complete av heart block
taking methyldopa
days
stopping
drug
normal sinus rhythm
recurrent complete av heart block
cardiovascular
side effects
hypotension
sinus
av
nodal conduction disturbances
patients
cases of new av
nodal block
including mobitz types
complete av heart block
methyldopa
methyldopa
carotid sinus hypersensitivity
syncope in some patients
rare cases of myocarditis
hepatitis
pneumonitis
paradoxical hypertension
immunologic side effects
development of a positive antinuclear antibody
ana
titer
systemic lupus-like syndrome
retroperitoneal fibrosis
immunoblastic lymphadenopathy
lymphoma
year-old man with hypertension
hemolytic anemia
arthritis
photosensitivity
ana against class h histones months
beginning methyldopa
syndrome
laboratory abnormalities
drug discontinuation
steroid therapy
nervous system
side effects
dizziness
insomnia in less
general fatigue
headache
patients
new
choreoathetotic movements
exacerbations of parkinsonian symptoms
gastrointestinal side effects
diarrhea
nausea
patients
rare case reports of pancreatitis
colitis
case
black tongue
year-old man with hypertension
diabetic ketoacidosis
dka
weeks
beginning methyldopa
mg per day
naive rechallenge of the drug
months
recurrent dka
ultrasonographic evidence of pancreatitis
patient
signs of chronic pancreatitis
including weight loss
steatorrhea
pancreatic calcification
hypersensitivity reactions
rare reports of vasculitis
rash
drug fever
anaphylactoid-like reactions
case reports of methyldopa-associated profound hypotension
fever
chills
diarrhea
leukocytosis
negative blood cultures
elderly patients
case rechallenges
dermatologic adverse side effects
case reports of sun-exposed rashes
hyperpigmentation
nodular rashes
lichenoid eruptions
endocrine side effects
amenorrhea
galactorrhea
resulting from methyldopa-induced hyperprolactinemia
case of inappropriate secretion of antidiuretic hormone
methyldopa
active ingredient
aldomet
year-old man with hypertension
hyponatremia
urine
serum osmolality ratio
standard water test
methyldopa
less free water excretion with the drug
patient
bone marrow
noncaseating granulomas
evidence of thyroid
cns disease
tuberculous infection
patient
hyponatremia
abnormal liver function tests
abnormal bone marrow findings
withdrawal of methyldopa
limited data
transient reductions in hdl lipoprotein cholesterol
middle-aged men with hypertension
time
reduction
baseline values
psychiatric side effects
depression
patients
case reports of paranoia
forgetfulness
year-old man
mania within weeks
switching from methyldopa
nifedipine
antihypertensive therapy
study of elderly patients
ages
pretreatment dementia
methyldopa
decreased ability
object assembly tasks
depression
placebo
genitourinary complaints of impotence among male patients
limited data
methyldopa
active ingredient
aldomet
urine in some patients
providing
nidus for calcium phosphate calculi
study of men
impotence
study of males with hypertension
decreased libido
inability
erections
difficulty in ejaculation
year-old chemist
methyldopa
active ingredient
aldomet
nasal congestion
sneezing
exertional wheezing
demonstrable fall in fev
signs
symptoms
environmental exposure
methyldopa
antibodies
methyldopa
respiratory side effects
nasal congestion in less
patients
rare case of bronchospasm
chemist
methyldopa
fever
starting
medicine
swelling of feet
lower legs
mental depression
anxiety
nightmares
vivid dreams
amber urine
diarrhea
stomach cramps
continuing
fever
chills
breathing
heartbeat
general feeling of discomfort
illness
weakness
joint pain
pale stools
skin rash
itching
stomach pain
nausea
vomiting
tiredness
weakness
having
medicine for several weeks
continuing
yellow eyes
skin
drowsiness
dryness of mouth
headache
decreased sexual ability
interest in sex
diarrhea
dizziness
lightheadedness
getting
lying
sitting position
nausea or vomiting 
numbness
tingling
pain
weakness in hands
feet
slow heartbeat
stuffy nose
swelling of breasts
unusual milk production